Hamostaseologie

Papers
(The TQCC of Hamostaseologie is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Veranstaltung des BDDH am 03.03.2022 im Rahmen der 66. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Leipzig63
Gründung des Fachausschusses für das Deutsche Hämophilieregister (DHR) und Medizinische Informationsobjekte (MIO)35
GTH 2025 ARTE: The Art in Science – Curiosity and Creativity22
Medizinforschungsgesetz, Apothekenreform-Gesetz, Telemedizin Blutspende-Verordnung, Erweiterung der Dokumentationspflichten im Deutschen Hämophilieregister (DHR)19
Current Topics from the Revised German S2k Guideline on Diagnosis and Treatment of Venous Thromboembolism18
Übergewicht und Adipositas erhöht Risiko für venöse Thromboembolien17
Erratum: Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung16
16
ITAM upregulation in platelets after major surgery13
A novel assay to quantify extrinsic tenase complexes in body fluids13
Asundexian and milvexian: Pharmacodynamic insights from coagulation assays13
Platelet activating histone/anti-histone immune complexes are associated with a new entity of thrombosis and thrombocytopenia syndrome12
Tolerance Breakdown in Hemophilia A Mice is Orchestrated by Bacterial Infection Modulating Antigen-Specific B and T cell Responses12
Current Concepts of Pathogenesis and Treatment of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms11
11
Hemophilia care from pediatrics to adulthood – a model of joint interdisciplinary guided transition at a Hemophilia Comprehensive Care Center (HCCC)10
Assessing the impact of a pulmonary embolism response team on patients presenting with intermediate risk acute pulmonary embolism. A prospective study (ongoing)10
Elevated von Willebrand factor levels during anticoagulation predict early recurrence of venous thromboembolism9
Long-term management of deep vein thrombosis based on medical history - A prospective cohort analysis9
Gabapentin and pregabalin can be associated with clinically relevant bleeding due to disturbed platelet function – Two case reports8
Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant Treatment7
The Current Evidence of Pulmonary Embolism Response Teams and Their Role in Future7
High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India7
Platelets in Myocardial Ischemia/Reperfusion Injury7
Subsegmental Pulmonary Embolism7
Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods—One-Center Experience7
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert7
Komplementdysregulation als Biomarker für Post Covid7
Checkpoint Inhibitors, CAR T Cells, and the Hemostatic System: What Do We Know So Far?7
Blutspende auch ohne Arztanwesenheit und aktueller Stand des Apothekenreform-Gesetzes (ApoRG)6
Targeting antigen-specific B cells in immune mediated thrombotic thrombocytopenic purpura using modular CAR T cells6
A Vicious Circle of Clonal Haematopoiesis of Indeterminate Potential and Cardiovascular Disease6
Differential platelet activation and thrombo-inflammatory mechanisms in early onset and late onset preeclampsia6
Efficacy of Rivaroxaban in Children with Short Bowel Syndrome6
Management of Hemophilia C (Factor XI Deficiency) in Two Families: A Case Study at the University Hospital of Halle (Saale)6
Autoantibody-induced platelet Fc-gamma-RIIA-mediated procoagulant platelets are important drivers of immunothrombosis in antiphospholipid syndrome6
Increased transfusion requirement in children compared to adults undergoing cardiac surgery6
Thrombocytopenia Absent Radius (TAR)-Syndrome: From Current Genetics to Patient Self-Empowerment5
Results of an international survey (ISTH) on the management of therapeutic-intensity unfractionated heparin5
Evidence in Haemophilia Assessment: The Haemophilia Joint Health Score5
Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion5
Pregnancy complications in female haemophilia patients and carriers of haemophilia A and B- a nationwide survey5
Venous Thromboembolism in Women with Cancer with an Additional Focus on Breast and Gynecological Cancers5
Enhanced platelet turnover after acute myocardial infarction in thrombocytopenic mice and GPVI-deficient mice5
Management of Antithrombin Deficiency in Pregnancy5
Erratum: A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia4
Venous Thrombosis and SARS-CoV-24
Familial Protein S deficiency with severe venous thromboembolism (VTE)4
Hypofibrinolytic dysregulations can be detected of frozen plasma samples using viscoelastic testing4
Runder Tisch zum deutschen Hämophilieregister (DHR), drohender Praxenkollaps, Stand und Zukunft der ambulanten hämostaseologischen Versorgung in Deutschland4
GTH News4
The Impact of non-factor VIII therapy in haemophilia A on procoagulant platelets4
Reference Intervals in Coagulation Analysis4
Correlation between Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio and Burden of Thrombus with Disease Severity in Patients with Pulmonary Thromboembolism4
Influence of coagulation proteases on cognitive function4
Petition „Vergütung für medizinische Leistungen – Verbesserung der Rahmenbedingungen für die ambulante Versorgung“, ATMP-QS-Richtlinie Hämophilie und aktueller Stand zur Digitalisierung im Gesundheits4
Communication in Healthcare: Global challenges in the 21st Century3
Treatment of Inherited Platelet Disorders: Current Status and Future Options3
GTH News3
Changes in Hemophilia Treatment in the Eastern Part of Germany between 2015 and 2021—Data from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)3
Nonfactor Therapies: New Approaches to Prophylactic Treatment of Haemophilia3
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis3
Platelets and COVID-193
Gleiches Risiko für schwere kardiovaskuläre Ereignisse nach hämorrhagischem und ischämischem Schlaganfall3
Acquired von Willebrand Syndrome in Children3
A patient with Klippel-Trénaunay-Syndrom and cerebral venous sinus thrombosis3
Bleeding Risk in Patients with Cancer3
Role of Tissue Transglutaminase 2 in Fibrin Formation and Haemostasis3
3
Inhibition of MicroRNA-122-5p Relieves Myocardial Ischemia-Reperfusion Injury via SOCS13
Neuigkeiten zur Ablösung der geplanten Ablösung der In-Vitro-Diagnostika-Richtlinie durch die In-Vitro-Diagnostika-Verordnung (IVDR) 05/2022 und Plasmaversorgung in Deutschland/EU und Fortführung der 3
Update des Versorgungsvertrages nach § 132 i SGBV3
Recognizing inherited platelet disorders on the peripheral blood smear by immunofluorescence microscopy: results of the first international workshop3
Diagnosis of Platelet Function Disorders: A Challenge for Laboratories3
Endothelial Mechanisms Modulate the Prothrombotic Phenotype of Factor V Leiden Carriers: Evidence from an Ex Vivo Model3
The Use of Large Animal Models in Trauma and Bleeding Studies3
Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders3
Development and evaluation of a novel machine learning algorithm for outpatient thrombophilia diagnosis, management, and venous thrombosis risk stratification3
Veranstaltung des BDDH im Rahmen der 67. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung in Frankfurt3
Echtzeit-Bildgebung der durch Blutplättchen induzierten Blutgerinnselbildung und -auflösung zeigt unterschiedliche Auswirkungen von Antikoagulantien3
Recombinant factor VIII binding to platelets influences fibrin clot formation and stability2
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline2
In Japan 40% Blutungskomplikationen während ECMO-Therapie bei COVID-192
A Review of FXIa Inhibition as a Novel Target for Anticoagulation2
Determination of thrombotic risk in patients with antiphospholipid syndrome using a modified thrombin generation assay2
Transfusion älterer Erythrozyten erhöht Mortalität und Thromboembolie-Risiko2
2
Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence2
Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology2
Genetic Analysis of Hereditary Coagulation Factor V Deficiency in Two Chinese Families Caused by Compound Heterozygous Mutations2
Treatment of Atypical Clots2
Investigating the impact of oligogenic variation on severity of bleeding in hypofibrinogenemia2
Haemostaseological pearls2
Venous Thromboembolism Issues in Women2
The Great Return: Rebuilding and Advancing the Swiss Haemophilia Registry2
Stable Factor IX Expression and Sustained Reductions in Factor IX Use 8 Years After Gene Therapy With CSL220 (Formerly AMT-060) in Adults with Hemophilia B [ENCORE]2
Residuale Venenokklusion nach längerer Antikoagulanzien-Therapie nicht mit erneuten venösen Thromboembolien assoziiert2
Identification of novel cryptic epitopes uncovers a distinct and consistent open ADAMTS13 conformation in iTTP2
Geringe α-Thrombin/GPIbα-Interaktion trägt möglicherweise zur Hyperreaktivität der Thrombozyten bei COVID-19-Patienten bei2
GTH News2
Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives2
Laudatio auf Rüdiger E. Scharf1
Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group1
Promoting young talents - “Coagulation for bloody beginners” („Gerinnung für blutige Anfänger*innen“)1
Intensive lifestyle intervention on thrombin generation in individuals at high risk for type 2 diabetes1
Guidance-Based Appropriateness of Hemostasis Testing in the Acute Setting1
Reform des Kapitels 32 (Laboratoriumsmedizin) im einheitlichen Bewertungsmaßstab (EBM)1
Managing immune thrombocytopenia (ITP) during pregnancy- Single centre 15 years experience at a tertiary care institute1
Intravital Imaging of Thrombosis Models in Mice1
Evaluating the prevalence and profile of antibodies against Polyethylene Glycol in hemophilia patients and healthy Individuals1
Fibrin exposition on the surface of the remaining part of arterial thrombus arrests the thrombus growth1
Digenic Inheritance of PROC and SERPINC1 Mutations Contributes to Multiple Sites Venous Thrombosis1
Successful Secondary Endovascular Intervention in Pediatric Patients with Venous Thromboembolic Events1
vWF/GPIb mechano-dependent interactions require F-actin disassembly by the oxidoreductase MICAL11
Noncanonical Regulation of ACKR3/CXCR7 on Lipid Mediators in Immunothrombotic Platelet Response following FcγRIIa Stimulation1
Treatment Burden during a Phase 3 Randomized, Crossover Study of Recombinant ADAMTS13 Prophylaxis and Standard of Care in Patients with Congenital Thrombotic Thrombocytopenic Purpura1
Management of Vascular Thrombosis in Patients with Thrombocytopenia1
Apixaban for thromboprophylaxis in paediatric cardiology patients – Real-world data from a single institution1
The Potential of HMB-001 as a Prophylactic Treatment of Glanzmann Thrombasthenia: Interim Analysis of the Phase 2 Study1
NBEAL2 related Gray Platelet Syndrome with a combined platelet granules secretion defect in flow cytometry1
Progress in Hemostasis (Part 1): Improved Management of Inherited Platelet Disorders: Reality or Illusion?1
Novel Perspectives on Thrombopoietin Receptor Agonists Applications1
Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis1
1
Quantifying Residual Rivaroxaban Plasma Concentration after Antagonization with Andexanet Alfa: A Difficult Task in Routine Clinical Practice1
First Interim Analysis of Clinical Outcomes in Adults and Adolescents With Severe Hemophilia A Receiving Efanesoctocog Alfa Prophylaxis in XTEND-ed, a Phase 3 Long-term Extension Study1
Animal and Cellular Models in Thrombosis and Hemostasis1
Platelet Dysregulation in the Pathobiology of COVID-191
Marker der Akute-Phase-Reaktion könnten Blutungen bei Hämophilie detektieren1
Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: Third interim analysis of the non-interventional study EMIIL1
Osteoporosis Remains Constant in Patients with Hemophilia—Long-Term Course in Consideration of Comorbidities1
Leichte Schlaganfälle: Thrombolyse und routinemäßige medi-zinische Versorgung im Vergleich1
Post Partum Haemorrhage: prepartum plasmin and thrombin generation is similar in women with and without PPH1
Glycoprotein-specific antibodies modulates platelet phenotypes in an epitope-dependent manner1
Erhöhte Faktor-VIII-Aktivität – gesteigertes Risiko für Pfortaderthrombosen1
Chronic Venous Disease: Pathophysiological Aspects, Risk Factors, and Diagnosis1
Clot-Wave-Analyse könnte individualisierte Therapie bei Hämophilie A verbessern1
GTH News1
The evidence of enlarged platelets with reduced expression of glycoprotein Ib/IX might indicate recessive inherited thrombocytopenias other than Bernard-Soulier Syndrome1
Fine-Tuning of Platelet Responses by Serine/Threonine Protein Kinases and Phosphatases—Just the Beginning1
From Code to Clots: Applying Machine Learning to Clinical Aspects of Venous Thromboembolism Prevention, Diagnosis, and Management1
Microvascular Skin Manifestations Caused by COVID-191
Use of Vonicog Alpha and Acquired von Willebrand Syndrome, a New Approach: A Case Report1
Advancing Treatment Options: Two Phase 3 Studies Investigating the Efficacy, Safety, and Pharmacokinetics of an Antithrombin Concentrate in Patients with Congenital and Acquired Antithrombin Deficienc1
Feasibility of a VWF:Ag latex immunoassay on a fully automated coagulation analyzer1
0.092770099639893